Related Experiment Video
Updated: May 11, 2026
09:46
Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing
Lilach Soreq1, Nathan Salomonis, Michal Bronstein
1Department of Medical Neurobiology, Hadassah Faculty of Medicine, The Hebrew University of Jerusalem Jerusalem, Israel.
Frontiers in Molecular Neuroscience
|May 30, 2013
Summary
This study profiles microRNAs (miRNAs) in Parkinson's disease (PD) patients, revealing altered miRNA expression before and after deep brain stimulation (DBS). Findings identify potential therapeutic targets for PD and assess DBS impact on molecular networks.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Parkinson's disease (PD) is a leading neurodegenerative disorder with incompletely understood molecular mechanisms.
- MicroRNAs (miRNAs) are crucial post-transcriptional regulators, but their role in PD pathogenesis remains largely uncharacterized.
- Deep brain stimulation (DBS) is a therapeutic intervention for PD, yet its molecular effects require further elucidation.
Purpose of the Study:
- To comprehensively profile miRNA expression in Parkinson's disease patients before and after deep brain stimulation (DBS) treatment.
- To identify novel molecular targets and networks associated with PD and its therapeutic modulation by DBS.
- To investigate the impact of DBS on leukocyte RNA profiles and cellular composition.
Main Methods:
- Next-generation small-RNA sequencing for miRNA profiling.
- Splice-junction and exon arrays for transcript isoform analysis.
- Functional enrichment and network analysis of identified molecular changes.
Main Results:
- Identified 254 miRNAs and 79 passenger strand forms in leukocytes; 16 miRNAs were altered in PD patients pre-treatment.
- Observed 11 miRNA changes post-DBS, with 5 inversely affected compared to disease changes.
- Detected 332 altered transcript isoforms in PD patients, highlighting mitochondrion organization and immune cell activity.
- Discovered predictable targeting of 217 disease and 74 treatment isoforms by modified miRNAs.
Conclusions:
- The study presents dynamic miRNA-target networks offering novel therapeutic targets for Parkinson's disease.
- Findings advance the understanding of the molecular basis of neurodegenerative diseases and the effects of brain stimulation.
- Identified molecular signatures provide insights into disease progression and treatment response in PD.
